Background Parenchymal Enhancement at Breast MR Imaging and Breast Cancer Risk

被引:281
|
作者
King, Valencia [1 ]
Brooks, Jennifer D. [2 ]
Bernstein, Jonine L. [2 ]
Reiner, Anne S. [2 ]
Pike, Malcolm C. [2 ]
Morris, Elizabeth A. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, Evelyn H Lauder Breast Ctr, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Evelyn H Lauder Breast Ctr, New York, NY 10065 USA
关键词
HORMONE REPLACEMENT THERAPY; CONTRAST-MEDIUM ENHANCEMENT; MAMMOGRAPHIC FEATURES; MENSTRUAL-CYCLE; TISSUE; DENSITY; WOMEN; PATTERNS; CLASSIFICATION; AGE;
D O I
10.1148/radiol.11102156
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To examine the relationships between breast cancer and both amount of fibroglandular tissue (FGT) and level of background parenchymal enhancement (BPE) at magnetic resonance (MR) imaging. Materials and Methods: A waiver of authorization was granted by the institutional review board for this retrospective HIPAA-compliant study. Among 1275 women who underwent breast MR imaging screening between December 2002 and February 2008, 39 breast carcinoma cases were identified. Two comparisons were performed: In one comparison, two normal controls-those of the women with negative (benign) findings at breast MR imaging-were matched to each breast cancer case on the basis of age and date of MR imaging. In the second comparison, one false-positive control-that of a woman with suspicious but nonmalignant findings at MR imaging-was similarly matched to each breast cancer case. Two readers independently rated the level of MR imaging-depicted BPE and the amount of MR imaging-depicted FGT by using a categorical scale: BPE was categorized as minimal, mild, moderate, or marked, and FGT was categorized as fatty, scattered, heterogeneously dense, or dense. Results: Compared with the odds ratio (OR) for a normal control, the OR for breast cancer increased significantly with increasing BPE: The ORs for moderate or marked BPE versus minimal or mild BPE were 10.1 (95% confidence interval [CI]: 2.9, 35.3; P < .001) and 3.3 (95% CI: 1.3, 8.3; P = .006) for readers 1 and 2, respectively. Similar odds were seen when the false-positive controls were compared with the breast cancer cases: The ORs for moderate or marked BPE versus minimal or mild BPE were 5.1 (95% CI: 1.4, 19.1; P = .005) and 3.7 (95% CI: 1.2, 11.2; P = .013) for readers 1 and 2, respectively. The breast cancer odds also increased with increasing FGT, but the BPE findings remained significant after adjustment for FGT. Conclusion: Increased BPE is strongly predictive of breast cancer odds. (C) RSNA, 2011
引用
收藏
页码:50 / 60
页数:11
相关论文
共 50 条
  • [1] Fibroglandular Tissue and Background Parenchymal Enhancement on Breast MR Imaging Correlates With Breast Cancer
    Hu, Xiaoxin
    Jiang, Luan
    You, Chao
    Gu, Yajia
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] Effect of the Menstrual Cycle on Background Parenchymal Enhancement in Breast MR Imaging
    Kajihara, Mariko
    Goto, Mariko
    Hirayama, Yukari
    Okunishi, Shoko
    Kaoku, Setsuko
    Konishi, Eiichi
    Shinkura, Nobuhiko
    MAGNETIC RESONANCE IN MEDICAL SCIENCES, 2013, 12 (01) : 39 - 45
  • [3] Is Background Parenchymal Enhancement in Breast Magnetic Resonance Imaging Associated with Breast Cancer?
    Alikhassi, Afsaneh
    Kia, Sona Akbari
    Yazdi, Seyedeh Nooshin Miratashi
    Akbari, Hedieh
    Roozafzai, Farzin
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2018, 11 (05)
  • [4] Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer
    Telegrafo, Michele
    Rella, Leonarda
    Ianora, Amato Antonio Stabile
    Angelelli, Giuseppe
    Moschetta, Marco
    MAGNETIC RESONANCE IMAGING, 2016, 34 (02) : 173 - 176
  • [5] Reply to "Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer"
    Bennani-Baiti, Barbara
    Baltzer, Pascal A.
    MAGNETIC RESONANCE IMAGING, 2016, 34 (09) : 1337 - 1338
  • [6] Correlation of background parenchymal enhancement on breast MRI with breast cancer
    Sallam, H.
    Lenga, L.
    Solbach, C.
    Becker, S.
    Vogl, T. J.
    CLINICAL RADIOLOGY, 2023, 78 (09) : e654 - e659
  • [7] Mammographic density, MRI background parenchymal enhancement and breast cancer risk
    Pike, M. C.
    Pearce, C. L.
    ANNALS OF ONCOLOGY, 2013, 24 : 37 - 41
  • [8] Clinical Significance of Background Parenchymal Enhancement in Breast Cancer Risk Stratification
    Murakami, Wakana
    Mortazavi, Shabnam
    Yu, Tiffany
    Kathuria-Prakash, Nikhita
    Yan, Ran
    Fischer, Cheryce
    McCann, Kelly E.
    Lee-Felker, Stephanie
    Sung
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2024, 59 (05) : 1742 - 1757
  • [9] Quantitative Measures of Background Parenchymal Enhancement Predict Breast Cancer Risk
    Niell, Bethany L.
    Abdalah, Mahmoud
    Stringfield, Olya
    Raghunand, Natarajan
    Ataya, Dana
    Gillies, Robert
    Balagurunathan, Yoganand
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2021, 217 (01) : 64 - 74
  • [10] Breast cancer and background parenchymal enhancement at breast magnetic resonance imaging: a meta-analysis
    Hu, Na
    Zhao, Jinghao
    Li, Yong
    Fu, Quanshui
    Zhao, Linwei
    Chen, Hong
    Qin, Wei
    Yang, Guoqing
    BMC MEDICAL IMAGING, 2021, 21 (01)